WO2015122477A1 - フィルムコーティングされた口腔内崩壊錠 - Google Patents
フィルムコーティングされた口腔内崩壊錠 Download PDFInfo
- Publication number
- WO2015122477A1 WO2015122477A1 PCT/JP2015/053880 JP2015053880W WO2015122477A1 WO 2015122477 A1 WO2015122477 A1 WO 2015122477A1 JP 2015053880 W JP2015053880 W JP 2015053880W WO 2015122477 A1 WO2015122477 A1 WO 2015122477A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- orally disintegrating
- film coating
- disintegrating tablet
- coated
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Definitions
- the present invention relates to a film-coated orally disintegrating tablet.
- Orally disintegrating tablets are oral solid preparations that disintegrate rapidly in the oral cavity with only saliva in the oral cavity or a small amount of water in about 30 seconds or less. Orally disintegrating tablets are easy-to-take preparations for patients because they disintegrate rapidly in the oral cavity, and their needs are increasing especially for elderly people and children with weak swallowing ability.
- orally disintegrating tablets due to the effects of sugars and disintegrants formulated to enhance disintegration, tablets are generally lower in hardness than ordinary oral solid preparations and are hygroscopic even immediately after production. Many have sex. Therefore, many orally disintegrating tablets are difficult to store or package in high humidity conditions.
- film coating is widely performed for the purpose of maintaining hardness and suppressing hygroscopicity.
- Film coating is applied for the purpose of protecting or stabilizing active ingredients from environmental factors such as humidity and light. Alternatively, it is also performed for the purpose of imparting moisture resistance to the tablet by film coating and maintaining the hardness of the tablet. Film coating is also often performed to mask drug bitterness and odor.
- the active ingredient is a highly active ingredient such as an anticancer agent or a hormonal agent, exposure of the highly active ingredient to medical personnel should be avoided as well as the distribution process, Unnecessary exposure is undesirable for the patient.
- Film coating is considered useful in terms of safety measures against such exposure.
- the patient takes such a conventional film-coated oral solid preparation as it is with an appropriate amount of water. That is, the conventional film-coated oral solid preparation is taken without completely dissolving the film coating layer in the oral cavity of the patient.
- orally disintegrating tablets generally have lower tablet hardness than ordinary oral solid preparations and many of them have hygroscopic properties, so the application of the above film coating technology to orally disintegrating tablets is expected. In fact, several attempts have been made. However, when this film coating technique is applied to an orally disintegrating tablet, there are problems peculiar to the orally disintegrating tablet. Film-coated orally disintegrating tablets require that the film coating layer dissolves quickly in the oral cavity of the patient, followed by rapid disintegration of the tablet body. Naturally, when the film coating layer of the film-coated orally disintegrating tablet is dissolved in the patient's mouth, its taste and mouthfeel must be taken into consideration.
- Patent Document 1 describes that an oral solid preparation coated with a film coating agent having a blending weight ratio of methylcellulose and acrylic polymer of 5:95 to 60:40 is provided.
- Patent Document 1 describes a technique for forming an uncoated orally disintegrating tablet after coating granulated particles with the film coating agent.
- Patent Document 1 does not disclose a technique for film-coating the orally disintegrating tablet itself.
- covered with this method were 30 seconds or more until time until it felt bitterness, ie, a film coating layer melt
- Patent Document 2 discloses a coating agent in which macrogol 6000 or titanium oxide is added to a cellulose derivative such as hydroxymethylpropylcellulose, hydroxymethylcellulose, methylcellulose, etc., on an orally disintegrating dry-coated tablet comprising an inner core and a coating layer. Coating is described.
- Patent Document 3 discloses a compound selected from a polyvinyl alcohol polymer and a discoloration-inducing metal oxide for UV laser printing of characters and the like on the surface of an orally disintegrating tablet for the purpose of improving discrimination. A technique for film coating orally disintegrating tablets with a dispersed coating solution is described.
- Patent Document 2 the inventors of Patent Document 2 think that it is impossible to apply a film coating because a general orally disintegrating tablet does not have sufficient hardness.
- a new formulation called a dry-coated tablet for dissolution in the oral cavity was created.
- patent document 2 is what coated the said coating agent with respect to the dry-coated tablet for intraoral dissolution, and is different from the technique applicable to a general orally disintegrating tablet.
- the oral disintegration time of the orally disintegrating tablet was about 30 seconds, whereas in the coated orally disintegrating tablet, about 60 seconds. It is described that it was.
- the disintegration time in the oral cavity is extended by about 30 seconds by film coating, and there is a problem in practical use.
- Patent Document 4 at least 1 g of maltose, maltitol, sorbitol, xylitol, fructose, glucose, lactitol, isomaltose, lactose, erythritol, mannitol, trehalose, and sucrose is contained in 1 g or more of water at 20 ° C.
- a stable orally disintegrating coated tablet containing a drug excluding nalfrafin or a pharmacologically acceptable salt thereof coated with a coating layer having a ratio of 1: 0.1 to 1: 9 is described. .
- Patent Document 5 includes one or more water-soluble polymers selected from the group consisting of hypromellose, hydroxypropyl cellulose, water-soluble vinyl derivatives and starches, polyethylene glycol, polysorbate, propylene glycol, triacetin and An orally disintegrating film-coated tablet comprising a film coating layer containing one or more plasticizers selected from the group consisting of triethyl citrate is described.
- Patent Documents 4 to 5 although taking into consideration the dissolution time and plasticity of the film coating layer, details about the feeling of administration such as taste and mouth feel, and ease of manufacture, which are most important for orally disintegrating tablets. Has not been studied.
- Patent Document 6 a film coating of a cellulose resin which is at least one selected from methylcellulose, hypromellose, hydroxypropylcellulose and hypromellose acetate succinate, containing at least one sweetener.
- An object of the present invention is to provide a film-coated orally disintegrating tablet which has a short dissolution time of a film, has a good feeling of dosing and can be easily mass-produced.
- the present invention comprises a water-soluble and ethanol-insoluble film coating base, and at least one plasticizer selected from the group consisting of propylene glycol and polyethylene glycol that is liquid or semi-solid at room temperature.
- a film-coated orally disintegrating tablet characterized by being coated with a film coating composition is provided.
- the present invention comprises a water-soluble and ethanol-insoluble film coating base, and at least one plasticizer selected from the group consisting of propylene glycol and polyethylene glycol that is liquid or semi-solid at room temperature.
- the film coating composition may further contain an excipient and / or a disintegrant.
- the film coating base may be hypromellose.
- the polyethylene glycol may be Macrogol 200, Macrogol 300, Macrogol 400, Macrogol 600, Macrogol 1500, or Macrogol 1540.
- a film-coated orally disintegrating tablet with a short film dissolution time is provided. Also provided are film-coated orally disintegrating tablets that are easy for patients to take, including taste and mouthfeel. Furthermore, a film-coated orally disintegrating tablet that can be easily mass-produced is provided.
- a water-soluble and ethanol-insoluble film coating base and a liquid or semi-solid plasticizer at room temperature are contained, and the plasticizer is determined in a predetermined amount with respect to the weight of the film coating base. It has been found that the dissolution time of the film coating layer can be sufficiently shortened by coating the orally disintegrating tablet with the film coating composition contained in a proportion. As a result, it was found that good disintegration in the oral cavity and mouthfeel can be achieved simultaneously while maintaining the advantages of film coating, and the invention was completed.
- the film-coated orally disintegrating tablet according to the present invention will be described in detail.
- the film-coated orally disintegrating tablet of the present invention is not construed as being limited to the description of the embodiments and examples shown below.
- the film-coated orally disintegrating tablet according to the present invention was coated with a film coating composition containing a water-soluble and ethanol-insoluble film coating base and a liquid or semi-solid plasticizer at room temperature. It is characterized by.
- the film-coated orally disintegrating tablet according to the present invention comprises a water-soluble and ethanol-insoluble film coating base and a plasticizer that is liquid or semisolid at room temperature, and is based on the weight of the film coating base. And a film coating composition containing more than 10% by weight of a plasticizer.
- ethanol insoluble means a property that is hardly soluble, extremely hardly soluble, or hardly soluble in ethanol based on the solubility item of the 16th revised Japanese Pharmacopoeia.
- water-soluble and ethanol-insoluble film coating base to be added to the film coating composition according to the present invention include hypromellose (also referred to as hydroxypropylmethylcellulose or HPMC), polyvinyl alcohol (also referred to as PVA), polyvinyl alcohol and polyethylene.
- Kollicoat (registered trademark) IR which is a graft copolymer of glycol, may be used, but is not limited thereto.
- the film coating composition according to the present invention can achieve both the required tablet hardness and the short dissolution time of the film coating layer.
- an ethanol-soluble film coating base is not suitable for the film coating base according to the present invention.
- the film coating base used in the film coating composition according to the present invention hypromellose is most preferable.
- the composition for film coating according to the present invention has different grades of hypromellose (20 ° C., 2%) depending on the quality required for orally disintegrating tablets coated with film.
- the viscosity can be appropriately selected from the viscosity or molecular weight in the aqueous solution. For example, by using hypromellose having a viscosity of 3.0 mPa ⁇ s / molecular weight of 16000 (for example, TC-5E manufactured by Shin-Etsu Chemical Co., Ltd.), rapid film solubility can be obtained.
- viscosity 4.5 mPa ⁇ s / molecular weight: 22000 (for example, TC-5M from Shin-Etsu Chemical) and viscosity: 6.0 mPa ⁇ s / molecular weight: 35600 (for example, TC-5R from Shin-Etsu Chemical) It is possible to simultaneously obtain excellent film properties such as rapid film solubility and increased hardness. A wide variety of quality films can be obtained by appropriately combining the types and amounts of these hypromellose grades.
- the plasticizer added to the film coating composition of the present invention is, for example, at least one selected from the group consisting of propylene glycol (also referred to as PG) and liquid or semi-solid polyethylene glycol (also referred to as PEG) at room temperature.
- PG propylene glycol
- PEG liquid or semi-solid polyethylene glycol
- Various plasticizers can be used.
- semi-solid means a smooth petrolatum-like solid property.
- Macrogol 200, Macrogol 300, Macrogol 400, Macrogol 600, Macrogol 1500 or Macrogol 1540 can be used.
- a plasticizer that is solid at room temperature is not suitable for the film coating composition according to the present invention from the viewpoint of mouthfeel during taking.
- mouth feel means a slimy feeling when taking, the hardness of a film, and the like.
- triacetin and triethyl citrate have a bad taste and glycerin has a bad taste, so it is not preferable to use it alone as a plasticizer.
- triacetin, triethyl citrate and glycerin may be added in combination with polyethylene glycol or propylene glycol which is liquid or semi-solid at room temperature.
- the total weight of the film coating base and the plasticizer is preferably about 80% by weight with respect to the total weight of the components of the film coating composition. It is not limited to. The total weight of the film coating base and the plasticizer can be arbitrarily adjusted within a range in which a film can be formed.
- the film coating composition according to the present invention further contains at least one pharmacologically acceptable additive of commonly used excipients, disintegrants, lubricants, corrigents and colorants. Can do.
- excipient water-soluble saccharides are preferable.
- erythritol, D-mannitol, lactose hydrate, xylitol, isomalt, maltose and the like can be used, but are not limited thereto.
- two or more excipients may be added in combination to the film coating composition according to the present invention. By adding these excipients, it is possible not only to impart a refreshing feeling to the film coating layer, but also to promote the introduction of moisture during taking. As a result, the film can be dissolved more rapidly.
- the content of the excipient is not particularly limited, and can be arbitrarily adjusted as long as the film can be formed and a desired film strength can be obtained.
- the disintegrant added to the film coating composition according to the present invention may be any pharmacologically acceptable.
- a disintegrating agent added to the film coating composition according to the present invention for example, crospovidone, sodium starch glycolate, croscarmellose sodium, low-substituted hydroxypropyl cellulose (also referred to as L-HPC) and the like can be used. However, it is not limited to these.
- the lubricant added to the film coating composition according to the present invention may be any pharmacologically acceptable.
- a lubricant to be added to the film coating composition according to the present invention for example, talc, light anhydrous silicic acid, magnesium stearate, calcium stearate, sodium stearyl fumarate, sucrose fatty acid ester and the like can be used. It is not limited to these.
- the content of the lubricant is not particularly limited, and can be arbitrarily adjusted within a range in which a film can be formed.
- the taste-masking agent added to the film coating composition according to the present invention only needs to be pharmacologically acceptable.
- the corrigent added to the film coating composition according to the present invention include sugars such as sucrose, lactose and glucose, sugar alcohols such as mannitol, erythritol, xylitol and sorbitol, sucralose, aspartame, acesulfame potassium, thaumatin and the like. Although it can be used, it is not limited to these. Although there is no restriction
- the colorant added to the film coating composition according to the present invention may be any pharmacologically acceptable.
- examples of the colorant added to the film coating composition according to the present invention include magnesium oxide, zinc oxide, aluminum oxide, anatase-type or rutile-type titanium oxide, iron sesquioxide, yellow sesquioxide, and the like, Water-soluble food tar pigments such as food yellow No. 5 and food blue No. 2 can be used, but are not limited thereto.
- the tablet body of the film-coated orally disintegrating tablet according to the present invention that is, the uncoated orally disintegrating tablet is not particularly limited, and is a general orally disintegrating tablet.
- the manufacturing method can also use a well-known technique, and is not specifically limited.
- a film coating composition and a plasticizer are dissolved in a solvent such as purified water to prepare a film coating composition.
- a solvent such as purified water
- at least one pharmacologically acceptable additive of an excipient, a disintegrant, a lubricant, a corrigent and a colorant may be further added.
- saccharides and disintegrants that are excipients impart a refreshing feeling to the film coating layer, and can be quickly dissolved by facilitating the introduction of moisture during administration. It is preferable to add to the composition.
- the film coating method for the uncoated orally disintegrating tablet is not particularly limited, and the uncoated orally disintegrating tablet is introduced into a widely used coating machine or sugar-coated bread, and the film coating composition according to the present invention is applied. Can be added.
- the film-coated orally disintegrating tablet according to the present invention imparts sufficient tablet strength and stability to the orally disintegrating tablet by coating with a film coating composition having a specific composition. , Handling convenience can be improved.
- the film-coated portion dissolves rapidly, exhibits good mouthfeel, and maintains good disintegration property in the oral cavity. Even when an uncoated orally disintegrating tablet contains a highly active ingredient as an active ingredient, film coating with the film coating composition of the present invention does not expose the highly active ingredient to the surface of the tablet. Necessary exposure is prevented and it is useful for safety measures.
- the film-coated orally disintegrating tablet according to the present invention can be produced by widely used film coating processes and equipment without using special processes and equipment.
- Example 1 As Example 1, a film coating composition was prepared using hypromellose (HPMC) as a film coating base.
- HPMC hypromellose
- hypromellose TC-5E, Shin-Etsu Chemical Co., Ltd.
- macrogol 400 Nippon Oil
- erythritol Nihon Kasei
- cloth as a disintegrant Povidone (CL-F, BASF)
- talc Fluji talc
- sucralose P, Saneihara FFI
- Ti-10M titanium industry
- Example 2 Al lake were dissolved and dispersed to obtain a film coating composition.
- An uncoated orally disintegrating tablet (hardness: 6.0 kg) with a weight of 250 mg was prepared according to the reference example, and using the coating machine (HC-LABO20, Freund Industries), the uncoated orally disintegrating tablet was brought to a predetermined weight.
- the tablet-coated composition for film coating was used to produce the film-coated orally disintegrating tablet of Example 1.
- Example 2 As Example 2, a film coating composition was prepared using polyvinyl alcohol (PVA) as a film coating base.
- PVA polyvinyl alcohol
- a film-coated orally disintegrating tablet was produced in the same manner as in Example 1 except that polyvinyl alcohol (EG-05, Nippon Synthetic Chemical Industry) was added to purified water.
- Example 3 As Example 3, a film coating composition was prepared using Kollicoat (registered trademark) IR as a film coating base. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1 except that Kollicoat (registered trademark) IR (BASF) was added to purified water.
- Kollicoat registered trademark
- BASF Kollicoat
- Comparative Example 1 As Comparative Example 1, a film coating composition was prepared using hydroxypropyl cellulose (HPC) as a film coating base. An orally disintegrating tablet film-coated was produced in the same manner as in Example 1 except that hydroxypropylcellulose (SSL, Nippon Soda) was added to purified water.
- HPC hydroxypropyl cellulose
- Comparative Example 2 As Comparative Example 2, a film coating composition was prepared using polyvinyl pyrrolidone (PVP) as a film coating base. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1 except that polyvinylpyrrolidone (K-30, Daiichi Kogyo Seiyaku) was added to purified water.
- PVP polyvinyl pyrrolidone
- the film-coated orally disintegrating tablets of Examples 1 to 3 and Comparative Examples 1 and 2 were measured for visual productivity, sensory test, hardness measurement, and film dissolution time.
- Tablet hardness Tablet hardness was measured using a tablet hardness tester (DC-50, Okada Seiko).
- Example 4 Next, the plasticizer was examined.
- a film coating composition was prepared using Macrogol 1500 as a plasticizer.
- a film-coated orally disintegrating tablet was produced in the same manner as in Example 1 except that Macrogol 1500 (polyethylene glycol # 1500, Nacalai Tesque) was added to purified water.
- Example 5 a film coating composition was prepared using propylene glycol (PG) as a plasticizer.
- An orally disintegrating tablet coated with a film was produced in the same manner as in Example 1 except that propylene glycol (Wako Pure Chemical Industries) was added to purified water.
- PG propylene glycol
- Comparative Example 3 As Comparative Example 3, a film coating composition was prepared using Macrogol 6000 as a plasticizer. An orally disintegrating tablet coated with a film was produced in the same manner as in Example 1 except that Macrogol 6000 (Nippon Oil) was added to purified water.
- Macrogol 6000 Natural Oil
- Comparative Example 4 As Comparative Example 4, a film coating composition was prepared using triacetin as a plasticizer. An orally disintegrating tablet coated with a film was produced in the same manner as in Example 1 except that triacetin (Wako Pure Chemical Industries) was added to purified water.
- Comparative Example 5 As Comparative Example 5, a film coating composition was prepared using triethyl citrate as a plasticizer. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1 except that triethyl citrate (Morimura Corporation) was added to purified water.
- Comparative Example 6 As Comparative Example 6, a film coating composition was prepared using glycerin as a plasticizer. An orally disintegrating tablet coated with a film was produced in the same manner as in Example 1 except that glycerin (Wako Pure Chemical Industries) was added to purified water.
- Comparative Example 7 As Comparative Example 7, a film coating composition was prepared using D-sorbitol as a plasticizer. An orally disintegrating tablet coated with a film was produced in the same manner as in Example 1 except that D-sorbitol (Wako Pure Chemical Industries) was added to purified water.
- Comparative Example 8 As Comparative Example 8, a film coating composition was prepared using D-sorbitol as a plasticizer so that D-sorbitol was in a ratio of 1: 3 with respect to hypromellose. Orally disintegrating tablet film-coated as in Example 1 except that hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.) and D-sorbitol (Wako Pure Chemical Industries) were added to purified water and the blending ratio was changed. Manufactured.
- Comparative Example 8 In Comparative Example 6 using glycerin, the mouthfeel was poor. Further, in Comparative Example 7 using D-sorbitol, the mouthfeel was poor, and when the blending ratio of D-sorbitol to hypromellose was changed, pairing occurred during coating, and a film could not be formed (Comparative Example 8).
- Example 6 Next, the ratio of the plasticizer to the film coating base was further examined.
- Hypromellose was used as a film coating base, Macrogol 400 or propylene glycol as a plasticizer, and a combination of these with glycerin was examined.
- the film was the same as Example 1 except that hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.) and macrogol 400 (Nippon Oil) were added to purified water and the blending ratio was changed. Coated orally disintegrating tablets were prepared.
- Example 7 As Example 7, to the purified water, except that hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.), macrogol 400 (Nippon Oil) and glycerin (Wako Pure Chemical Industries) were added as plasticizers, and the blending ratio was changed. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1.
- Example 8 As Example 8, film was obtained in the same manner as Example 1 except that hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.) and propylene glycol (Wako Pure Chemical Industries) as plasticizer were added to purified water, and the blending ratio was changed. Coated orally disintegrating tablets were prepared.
- Example 9 As Example 9, hypromellose (TC-5E, Shin-Etsu Chemical) was added to purified water, propylene glycol (Wako Pure Chemical Industries) and glycerin (Wako Pure Chemical Industries) were added as plasticizers, and the blending ratio was changed. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1.
- Example 10 As Example 10, hypromellose (TC-5E, Shin-Etsu Chemical) was added to purified water, and propylene glycol (Wako Pure Chemical Industries) and glycerin (Wako Pure Chemical Industries) were added as plasticizers, and the blending ratio was changed. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1.
- Example 11 As Example 11, hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.) was added to purified water, propylene glycol (Wako Pure Chemical Industries) and glycerin (Wako Pure Chemical Industries) were added as plasticizers, and the blending ratio was changed. A film-coated orally disintegrating tablet was produced in the same manner as in Example 1.
- Example 12 In Example 12, except that hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.), propylene glycol (Wako Pure Chemical Industries) as a plasticizer, and maltose (PH, Hayashibara) as an excipient were further added to purified water. Produced a film-coated orally disintegrating tablet as in Example 1.
- Example 13 As Example 13, hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.) was added to purified water and propylene glycol (Wako Pure Chemical Industries) was added as a plasticizer, and the blending ratio was changed. Coated orally disintegrating tablets were prepared.
- Example 13 Furthermore, from the results of Example 13, by using a film coating composition containing more than 20% by weight of a plasticizer with respect to the weight of the film coating base, the manufacturability is good and the hardness by film coating It has been found that a film-coated orally disintegrating tablet with increased and good film solubility is obtained.
- a film coating composition was prepared using hypromellose (HPMC) as a film coating base and Macrogol 400 as a plasticizer. Purified water, hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.), macrogol 400 (Nippon Oil) as a plasticizer, talc (Fuji talc) as a lubricant, and titanium oxide as a colorant so that the prescription ratio shown in FIG. (KA-10M, Titanium Industry) was dissolved and dispersed to obtain a film coating composition.
- HPMC hypromellose
- Macrogol 400 Macrogol 400
- An uncoated orally disintegrating tablet (hardness: 6.0 kg) with a weight of 250 mg was prepared according to the reference example, and using the coating machine (HC-LABO20, Freund Industries), the uncoated orally disintegrating tablet was brought to a predetermined weight.
- the film-coating composition of Example 14 was produced by coating the tablet with the film coating composition.
- Example 15 As Example 15, the purified water was mixed with hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.), macrogol 400 (Nippon Oil) as a plasticizer, talc (Fuji talc) as a lubricant, A film coating composition was obtained by dissolving and dispersing sucralose (P, Saneihara FFI) as a corrigent and titanium oxide (KA-10M, Titanium Industry) as a colorant. An uncoated orally disintegrating tablet (hardness: 6.0 kg) with a weight of 250 mg was prepared according to the reference example, and using the coating machine (HC-LABO20, Freund Industries), the uncoated orally disintegrating tablet was brought to a predetermined weight. The film coating composition of Example 15 was produced by coating the tablet with the film coating composition.
- Example 16 As Example 16, the purified water was mixed with hypromellose (TC-5E, Shin-Etsu Chemical Co., Ltd.), macrogol 400 (Nippon Oil) as a plasticizer, and D-mannitol (P, as an excipient) so that the formulation ratio of FIG. Mitsubishi Corporation Foodtech), talc (Fuji talc) as a lubricant, sucralose (P, Saneihara FFI) as a corrigent, and titanium oxide (KA-10M, titanium industry) as a colorant are dissolved and dispersed into a film. A coating composition was obtained.
- hypromellose TC-5E, Shin-Etsu Chemical Co., Ltd.
- macrogol 400 Natural Oil
- D-mannitol P, as an excipient
- An uncoated orally disintegrating tablet (hardness: 6.0 kg) with a weight of 250 mg was prepared according to the reference example, and using the coating machine (HC-LABO20, Freund Industries), the uncoated orally disintegrating tablet was brought to a predetermined weight.
- the tablet-coated composition for film coating was used to produce the film-coated orally disintegrating tablet of Example 16.
- Example 17 As Example 17, a film coating composition was prepared using erythritol as an excipient. A film-coated orally disintegrating tablet was produced in the same manner as in Example 16 except that erythritol (Nikken Kasei) was added to purified water.
- Example 18 As Example 18, a film coating composition was prepared using lactose hydrate as an excipient. A film-coated orally disintegrating tablet was produced in the same manner as in Example 16 except that lactose hydrate (200M, manufactured by DMV) was added to purified water.
- Example 19 As Example 19, a film coating composition was prepared using xylitol as an excipient. A film-coated orally disintegrating tablet was produced in the same manner as in Example 16 except that xylitol (manufactured by ROQUETTE) was added to purified water.
- Example 20 As Example 20, a film coating composition was prepared using isomalt as an excipient. A film-coated orally disintegrating tablet was produced in the same manner as in Example 16 except that isomalt (galenIQ810, manufactured by BENEO-Palatinit) was added to purified water.
- isomalt galenIQ810, manufactured by BENEO-Palatinit
- talc (Fuji talc) as a lubricant
- sucralose P, Saneihara FFI
- titanium oxide K-10M, Titanium Industry
- a small amount of yellow ferric oxide and blue No. 2 Al The rake was dissolved and dispersed to obtain a film coating composition.
- An uncoated orally disintegrating tablet (hardness: 6.0 kg) having a weight of 250 mg was prepared, and a film coating composition prepared into an uncoated orally disintegrating tablet using a coating machine (HC-LABO20, Freund Industries). was coated to produce a film-coated orally disintegrating tablet.
- An uncoated orally disintegrating tablet (hardness: 6.0 kg) having a weight of 250 mg was prepared, and a film coating composition prepared into an uncoated orally disintegrating tablet using a coating machine (HC-LABO20, Freund Industries). Was coated to produce a film-coated orally disintegrating tablet.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本明細書において「エタノール不溶性」とは、第十六改正日本薬局方の溶解性の項目に基づき、エタノールに対して溶けにくい、極めて溶けにくい、又はほとんど溶けない性状を意味する。本発明に係るフィルムコーティング用組成物に添加する水溶性且つエタノール不溶性のフィルムコーティング基剤としては、例えば、ヒプロメロース(ヒドロキシプロピルメチルセルロース又はHPMCとも称す)、ポリビニルアルコール(PVAとも称す)、ポリビニルアルコールとポリエチレングリコールのグラフトコポリマーであるコリコート(登録商標)IR等を用いることもできるが、これらに限定されるものではない。水溶性且つエタノール不溶性のフィルムコーティング基剤を使用することにより、本発明に係るフィルムコーティング用組成物は、必要な錠剤硬度とフィルムコーティング層の短い溶解時間を両立させることができる。一方、水溶性であってもエタノール可溶性のフィルムコーティング基剤は、本発明に係るフィルムコーティング基剤には適さない。本発明に係るフィルムコーティング用組成物に使用するフィルムコーティング基剤としては、ヒプロメロースが最も好ましい。
本発明に係るフィルムコーティングされた口腔内崩壊錠の錠剤本体、すなわち、未被覆の口腔内崩壊錠は、特に限定されるものではなく、一般的な口腔内崩壊錠である。また、その製造方法も公知の技術を用いることができ、特に限定されない。
精製水などの溶媒にフィルムコーティング基剤及び可塑剤を溶解してフィルムコーティング用組成物を調製する。この時、賦形剤、崩壊剤、滑沢剤、矯味剤及び着色剤の少なくとも1種の薬理学的に許容可能な添加剤をさらに添加してもよい。特に、賦形剤である糖類及び崩壊剤は、フィルムコーティング層に清涼感を付与し、服用時の水分を導入しやすくすることで速やかな溶解が可能となるため、本発明に係るフィルムコーティング用組成物に添加することが好ましい。
フェキソフェナジン塩酸塩3.8g、D-マンニトール(P、三菱商事フードテック)294.5g、低置換度ヒドロキシプロピルセルロース(L-HPC(21)、信越化学工業)45.0g、アスパルテーム(味の素)7.5g、粉末還元麦芽糖水飴(アマルティMR-50、三菱商事フードテック)1.4gを高速撹拌練合機(FLS-GS-2J、深江工業)に入れ混合後、精製水100gを投入し練合した。練合品を篩8号で篩過した後、棚式乾燥機(40C、日空工業)に入れ乾燥した。乾燥品を整粒機(P-04-S、ダルトン)に入れ整粒した。整粒品にクロスポビドン(CL-F、BASF)11.3g、軽質無水ケイ酸(アドソリダー101、フロイント産業)3.8g、香料0.4g、フマル酸ステアリルナトリウム(PRUV、JRS Pharma)7.5gを混合し、打錠用混合品とした。打錠機(VELA5、菊水製作所)を用い、重量250mgおよび硬度6.0kgとなるよう打錠用混合品を打錠し未被覆の口腔内崩壊錠を得た。
実施例1として、フィルムコーティング基剤にヒプロメロース(HPMC)を用いて、フィルムコーティング用組成物を調製した。図1の処方比率となるよう、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)、賦形剤としてエリスリトール(日研化成)、崩壊剤としてクロスポビドン(CL-F、BASF)、滑沢剤としてタルク(富士タルク)、矯味剤としてスクラロース(P、三栄原エフエフアイ)、着色剤として酸化チタン(KA-10M、チタン工業)と微量の黄色三二酸化鉄及び青色2号Alレーキを溶解・分散し、フィルムコーティング用組成物を得た。重量250mgの未被覆の口腔内崩壊錠(硬度:6.0kg)を参考例に従って準備し、コーティング機(HC-LABO20、フロイント産業)を用いて、所定の重量になるよう未被覆の口腔内崩壊錠にフィルムコーティング用組成物をコーティングして実施例1のフィルムコーティングされた口腔内崩壊錠を製造した。
実施例2として、フィルムコーティング基剤にポリビニルアルコール(PVA)を用いて、フィルムコーティング用組成物を調製した。精製水に、ポリビニルアルコール(EG-05、日本合成化学工業)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例3として、フィルムコーティング基剤にコリコート(登録商標)IRを用いて、フィルムコーティング用組成物を調製した。精製水に、コリコート(登録商標)IR(BASF)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例1として、フィルムコーティング基剤にヒドロキシプロピルセルロース(HPC)を用いて、フィルムコーティング用組成物を調製した。精製水に、ヒドロキシプロピルセルロース(SSL、日本曹達)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例2として、フィルムコーティング基剤にポリビニルピロリドン(PVP)を用いて、フィルムコーティング用組成物を調製した。精製水に、ポリビニルピロリドン(K-30、第一工業製薬)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
未被覆の口腔内崩壊錠へのコーティング時の錠剤同士のペアリング(貼りつき)を目視で評価した。ペアリングを確認したものについては、コーティング工程としての適性に著しい問題があると考えられるため、コーティング性(製造性)は不可と判断した。
フィルムコーティングされた口腔内崩壊錠を用いた官能試験を実施し、(1)苦みの有無、および、(2)フィルムの溶解過程における口当たりを不快・やや不快・問題なしの3段階から評価を行った。
錠剤硬度計(DC-50、岡田精工)を用いて錠剤の硬度を測定した。
フィルムコーティングされた口腔内崩壊錠および未被覆の口腔内崩壊錠を用いた官能試験を行い、それぞれの口腔内崩壊時間を測定した。フィルムコーティングされた口腔内崩壊錠の口腔内崩壊時間と未被覆の口腔内崩壊錠の口腔内崩壊時間との差をフィルムの溶解時間として評価した。
次に、可塑剤の検討を行った。実施例4として可塑剤にマクロゴール1500を用いて、フィルムコーティング用組成物を調製した。精製水に、マクロゴール1500(ポリエチレングリコール#1500、ナカライテスク)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例5として可塑剤にプロピレングリコール(PG)を用いて、フィルムコーティング用組成物を調製した。精製水に、プロピレングリコール(和光純薬)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例3として可塑剤にマクロゴール6000を用いて、フィルムコーティング用組成物を調製した。精製水に、マクロゴール6000(日油)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例4として可塑剤にトリアセチンを用いて、フィルムコーティング用組成物を調製した。精製水に、トリアセチン(和光純薬)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例5として可塑剤にクエン酸トリエチルを用いて、フィルムコーティング用組成物を調製した。精製水に、クエン酸トリエチル(森村商事)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例6として可塑剤にグリセリンを用いて、フィルムコーティング用組成物を調製した。精製水に、グリセリン(和光純薬)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例7として可塑剤にD-ソルビトールを用いて、フィルムコーティング用組成物を調製した。精製水に、D-ソルビトール(和光純薬)を添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
比較例8として可塑剤にD-ソルビトールを用い、ヒプロメロースに対してD-ソルビトールが1:3の割合になるように、フィルムコーティング用組成物を調製した。精製水に、ヒプロメロース(TC-5E、信越化学工業)、D-ソルビトール(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
次に、フィルムコーティング基剤に対する可塑剤の割合について、さらに検討した。フィルムコーティング基剤としてヒプロメロースを用い、可塑剤としてマクロゴール400又はプロピレングリコール、さらに、それらにグリセリンを組合せたものについて検討した。実施例6として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例7として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)及びグリセリン(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例8として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例9として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)及びグリセリン(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例10として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)及びグリセリン(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例11として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)及びグリセリン(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例12として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)を添加し、賦形剤としてマルトース(PH、林原)をさらに添加したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例13として、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてプロピレングリコール(和光純薬)を添加し、その配合比率を変更したこと以外は実施例1と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
次に、賦形剤の検討を行った。フィルムコーティング基剤にヒプロメロース(HPMC)を用い、可塑剤としてマクロゴール400を用いて、フィルムコーティング用組成物を調製した。図5の処方比率となるよう、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)、滑沢剤としてタルク(富士タルク)、着色剤として酸化チタン(KA-10M、チタン工業)を溶解・分散し、フィルムコーティング用組成物を得た。重量250mgの未被覆の口腔内崩壊錠(硬度:6.0kg)を参考例に従って準備し、コーティング機(HC-LABO20、フロイント産業)を用いて、所定の重量になるよう未被覆の口腔内崩壊錠にフィルムコーティング用組成物をコーティングして実施例14のフィルムコーティングされた口腔内崩壊錠を製造した。
実施例15として、図5の処方比率となるよう、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)、滑沢剤としてタルク(富士タルク)、矯味剤としてスクラロース(P、三栄原エフエフアイ)、着色剤として酸化チタン(KA-10M、チタン工業)を溶解・分散し、フィルムコーティング用組成物を得た。重量250mgの未被覆の口腔内崩壊錠(硬度:6.0kg)を参考例に従って準備し、コーティング機(HC-LABO20、フロイント産業)を用いて、所定の重量になるよう未被覆の口腔内崩壊錠にフィルムコーティング用組成物をコーティングして実施例15のフィルムコーティングされた口腔内崩壊錠を製造した。
実施例16として、図5の処方比率となるよう、精製水に、ヒプロメロース(TC-5E、信越化学工業)、可塑剤としてマクロゴール400(日油)、賦形剤としてD-マンニトール(P、三菱商事フードテック製)、滑沢剤としてタルク(富士タルク)、矯味剤としてスクラロース(P、三栄原エフエフアイ)、着色剤として酸化チタン(KA-10M、チタン工業)を溶解・分散し、フィルムコーティング用組成物を得た。重量250mgの未被覆の口腔内崩壊錠(硬度:6.0kg)を参考例に従って準備し、コーティング機(HC-LABO20、フロイント産業)を用いて、所定の重量になるよう未被覆の口腔内崩壊錠にフィルムコーティング用組成物をコーティングして実施例16のフィルムコーティングされた口腔内崩壊錠を製造した。
実施例17として、賦形剤としてエリスリトールを用いて、フィルムコーティング用組成物を調製した。精製水に、エリスリトール(日研化成)を添加したこと以外は実施例16と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例18として、賦形剤として乳糖水和物を用いて、フィルムコーティング用組成物を調製した。精製水に、乳糖水和物(200M、DMV製)を添加したこと以外は実施例16と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例19として、賦形剤としてキシリトールを用いて、フィルムコーティング用組成物を調製した。精製水に、キシリトール(ROQUETTE製)を添加したこと以外は実施例16と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
実施例20として、賦形剤としてイソマルトを用いて、フィルムコーティング用組成物を調製した。精製水に、イソマルト(galenIQ810、BENEO-Palatinit製)を添加したこと以外は実施例16と同様にフィルムコーティングされた口腔内崩壊錠を製造した。
Claims (8)
- 水溶性且つエタノール不溶性のフィルムコーティング基剤と、プロピレングリコールならびに室温で液状又は半固形のポリエチレングリコールからなる群から選択される少なくとも1種の可塑剤と、を含むフィルムコーティング用組成物でコーティングされたことを特徴とするフィルムコーティングされた口腔内崩壊錠。
- 前記フィルムコーティング用組成物に賦形剤及び/又は崩壊剤をさらに含むことを特徴とする請求項1に記載のフィルムコーティングされた口腔内崩壊錠。
- 前記フィルムコーティング基剤がヒプロメロースであることを特徴とする請求項1に記載のフィルムコーティングされた口腔内崩壊錠。
- 前記ポリエチレングリコールは、マクロゴール200、マクロゴール300、マクロゴール400、マクロゴール600、マクロゴール1500又はマクロゴール1540であることを特徴とする請求項1に記載のフィルムコーティングされた口腔内崩壊錠。
- 水溶性且つエタノール不溶性のフィルムコーティング基剤と、プロピレングリコールならびに室温で液状又は半固形のポリエチレングリコールからなる群から選択される少なくとも1種の可塑剤と、を含み、
前記フィルムコーティング基剤の重量に対して、前記可塑剤を10重量%より多く含有するフィルムコーティング用組成物でコーティングされたことを特徴とするフィルムコーティングされた口腔内崩壊錠。 - 前記フィルムコーティング用組成物に賦形剤及び/又は崩壊剤をさらに含むことを特徴とする請求項5に記載のフィルムコーティングされた口腔内崩壊錠。
- 前記フィルムコーティング基剤がヒプロメロースであることを特徴とする請求項5に記載のフィルムコーティングされた口腔内崩壊錠。
- 前記ポリエチレングリコールは、マクロゴール200、マクロゴール300、マクロゴール400、マクロゴール600、マクロゴール1500又はマクロゴール1540であることを特徴とする請求項5に記載のフィルムコーティングされた口腔内崩壊錠。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES15748550T ES2856347T3 (es) | 2014-02-12 | 2015-02-12 | Comprimido desintegrante oralmente recubierto con película |
JP2015562867A JP6521874B2 (ja) | 2014-02-12 | 2015-02-12 | フィルムコーティングされた口腔内崩壊錠 |
EP15748550.9A EP3106152B1 (en) | 2014-02-12 | 2015-02-12 | Orally disintegrating tablet coated with film |
US15/233,534 US10588856B2 (en) | 2014-02-12 | 2016-08-10 | Orally disintegrating tablet coated with film |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-024524 | 2014-02-12 | ||
JP2014024524 | 2014-02-12 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/233,534 Continuation US10588856B2 (en) | 2014-02-12 | 2016-08-10 | Orally disintegrating tablet coated with film |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015122477A1 true WO2015122477A1 (ja) | 2015-08-20 |
Family
ID=53800217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/053880 WO2015122477A1 (ja) | 2014-02-12 | 2015-02-12 | フィルムコーティングされた口腔内崩壊錠 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10588856B2 (ja) |
EP (1) | EP3106152B1 (ja) |
JP (1) | JP6521874B2 (ja) |
ES (1) | ES2856347T3 (ja) |
WO (1) | WO2015122477A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018024632A (ja) * | 2016-08-02 | 2018-02-15 | エルメッド エーザイ株式会社 | 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物 |
JP2021134217A (ja) * | 2020-02-26 | 2021-09-13 | 日新製薬株式会社 | 被覆層を有する口腔内崩壊錠 |
US11826473B2 (en) | 2018-01-11 | 2023-11-28 | Sawai Pharmaceutical Co., Ltd. | Orally disintegrating tablet coated with film |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016108250A1 (en) | 2015-01-01 | 2016-07-07 | Ideal Cures Pvt. Ltd. | Novel film coating composition |
EP4119123A1 (en) | 2021-07-14 | 2023-01-18 | G.L. Pharma GmbH | Orally disintegrating film composition comprising buprenorphine |
EP4119124A1 (en) | 2021-07-14 | 2023-01-18 | Vektor Pharma TF GmbH | Microemulsion containing orally disintegrating film compositions with adjustable physical and rheological properties |
CN117159486B (zh) * | 2023-09-18 | 2024-03-19 | 浙江瓯伦包衣技术有限公司 | 一种口崩片包衣组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010248106A (ja) * | 2009-04-14 | 2010-11-04 | Dainippon Sumitomo Pharma Co Ltd | フィルムコーティング錠 |
WO2014157264A1 (ja) * | 2013-03-27 | 2014-10-02 | Meiji Seikaファルマ株式会社 | 口腔内崩壊性フィルムコーティング錠 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807580A (en) * | 1996-10-30 | 1998-09-15 | Mcneil-Ppc, Inc. | Film coated tablet compositions having enhanced disintegration characteristics |
CA2327685C (en) * | 1998-04-03 | 2008-11-18 | Bm Research A/S | Controlled release composition |
JP3718398B2 (ja) | 2000-01-11 | 2005-11-24 | 信越化学工業株式会社 | フィルムコーティング剤及び経口固形製剤 |
US6277409B1 (en) * | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
US20020119196A1 (en) * | 2000-12-21 | 2002-08-29 | Narendra Parikh | Texture masked particles containing an active ingredient |
US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
ES2271542T3 (es) | 2002-02-07 | 2007-04-16 | Pharmacia Corporation | Forma de dosificacion farmaceutica para administracion por la mucosa. |
SI21402A (sl) * | 2003-02-12 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Obloženi delci in farmacevtske oblike |
JP5080856B2 (ja) | 2007-05-14 | 2012-11-21 | 大正薬品工業株式会社 | 経口投与用錠剤 |
JP4852523B2 (ja) * | 2007-05-31 | 2012-01-11 | 花王株式会社 | 野菜汁及び/又は果汁含有容器詰飲料 |
US8153213B2 (en) * | 2009-03-30 | 2012-04-10 | Xerox Corporation | Polyimide polysiloxane intermediate transfer members |
TWI455733B (zh) | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
AR076540A1 (es) * | 2009-05-01 | 2011-06-22 | Eurand Inc | Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de analgesicos no- opioides y opioides, forma de dosificacion. metodo de preparacion. metodo para tratar dolor |
US20120189693A1 (en) * | 2009-06-25 | 2012-07-26 | Elite Laboratories, Inc. | Oral dosage forms |
EP2316433A1 (en) * | 2009-10-22 | 2011-05-04 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of flurbiprofen |
EP2601936A4 (en) * | 2010-08-03 | 2014-03-19 | Eisai R&D Man Co Ltd | COMPRESSED COMPOSITION |
JP5916091B2 (ja) | 2012-01-31 | 2016-05-11 | 大原薬品工業株式会社 | 口腔内崩壊錠のuvレーザー印刷方法 |
-
2015
- 2015-02-12 EP EP15748550.9A patent/EP3106152B1/en active Active
- 2015-02-12 JP JP2015562867A patent/JP6521874B2/ja active Active
- 2015-02-12 ES ES15748550T patent/ES2856347T3/es active Active
- 2015-02-12 WO PCT/JP2015/053880 patent/WO2015122477A1/ja active Application Filing
-
2016
- 2016-08-10 US US15/233,534 patent/US10588856B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010248106A (ja) * | 2009-04-14 | 2010-11-04 | Dainippon Sumitomo Pharma Co Ltd | フィルムコーティング錠 |
WO2014157264A1 (ja) * | 2013-03-27 | 2014-10-02 | Meiji Seikaファルマ株式会社 | 口腔内崩壊性フィルムコーティング錠 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018024632A (ja) * | 2016-08-02 | 2018-02-15 | エルメッド エーザイ株式会社 | 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物 |
US11826473B2 (en) | 2018-01-11 | 2023-11-28 | Sawai Pharmaceutical Co., Ltd. | Orally disintegrating tablet coated with film |
JP2021134217A (ja) * | 2020-02-26 | 2021-09-13 | 日新製薬株式会社 | 被覆層を有する口腔内崩壊錠 |
JP7219979B2 (ja) | 2020-02-26 | 2023-02-09 | 日新製薬株式会社 | 被覆層を有する口腔内崩壊錠 |
Also Published As
Publication number | Publication date |
---|---|
EP3106152B1 (en) | 2021-02-17 |
US10588856B2 (en) | 2020-03-17 |
US20160346199A1 (en) | 2016-12-01 |
ES2856347T3 (es) | 2021-09-27 |
JP6521874B2 (ja) | 2019-05-29 |
JPWO2015122477A1 (ja) | 2017-03-30 |
EP3106152A1 (en) | 2016-12-21 |
EP3106152A4 (en) | 2017-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6521874B2 (ja) | フィルムコーティングされた口腔内崩壊錠 | |
US8715730B2 (en) | Therapeutic or prophylactic agent for dyskinesia | |
JP5827299B2 (ja) | イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物 | |
JP2022003098A (ja) | シロドシンの苦味をマスキングした経口投与製剤 | |
JP2010248106A (ja) | フィルムコーティング錠 | |
TW201410268A (zh) | 加衣錠劑及彼之製法 | |
EP3437645B1 (en) | Film-coated tablet having high chemical stability of active ingredient | |
JP5818219B2 (ja) | 6,7−不飽和−7−カルバモイルモルヒナン誘導体含有製剤 | |
JP2015054851A (ja) | 被覆経口固形製剤 | |
JP5700367B2 (ja) | パロキセチン含有フイルムコ−テイング経口製剤 | |
JP2015110663A (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP6866153B2 (ja) | 圧縮成型製剤 | |
JP6151413B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP7202898B2 (ja) | フィルムコーティングされた口腔内崩壊錠 | |
JP7023186B2 (ja) | 認知症治療薬を含有する口腔内崩壊性錠剤 | |
JP6150564B2 (ja) | 口腔内速崩壊性錠剤 | |
WO2022196818A1 (en) | Coated solid pharmaceutical preparation | |
JP2021175742A (ja) | 温湿度安定性及び口腔内崩壊性に優れた口腔内崩壊性被覆錠剤 | |
JP2020105173A (ja) | 2種以上の薬物を含有する口腔内崩壊錠及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15748550 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015562867 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015748550 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015748550 Country of ref document: EP |